ビリルビン血液検査市場：検査タイプ、エンドユーザー、用途、製品別-2025年～2030年の世界予測

ビリルビン血液検査市場は、2023年に10億9,000万米ドルと評価され、2024年には12億米ドルに達すると予測され、CAGR 10.73％で成長し、2030年には22億3,000万米ドルに達すると予測されています。

ビリルビン血液検査市場には、血液中のビリルビン濃度を測定する診断手順が含まれ、肝疾患、溶血性貧血、新生児黄疸の診断とモニタリングに極めて重要です。これらの検査の必要性は、ライフスタイルの変化、アルコール消費、肝炎のようなウイルス感染によって引き起こされる肝障害の有病率の増加によって強調されています。最終用途には、主に病院、診断検査室、外来診療センターが含まれ、それぞれが患者管理を支援するために正確でタイムリーな診断サービスを必要としています。市場の成長は、高度な診断技術に対する需要の高まり、肝臓の健康に対する意識の高まり、肝臓疾患に罹患しやすい老年人口の増加などの影響を受けています。加えて、ポイントオブケア検査や非侵襲的診断ツールの開発といった技術革新が、大きな成長機会をもたらしています。より正確で利用しやすい検査法の研究開発に投資している企業は、急増する需要に資本投下する立場にあります。しかし、市場は厳しい規制要件や高度な検査技術に関連する高コストといった課題に直面しており、これが小規模検査施設や新興国を制約する可能性があります。技術革新の面では、検査精度と患者の転帰を向上させる人工知能主導の診断ツールの探求に有望な可能性があります。さらに、在宅環境におけるビリルビン検査のよりシームレスな統合に関する調査により、新たな市場セグメントが開拓される可能性があります。このような機会があるにもかかわらず、新興国市場における認知度の低さや不十分なヘルスケア・インフラが市場をやや制約しており、教育キャンペーンやインフラ投資の必要性が浮き彫りになっています。全体として、技術的進歩や戦略的提携を通じて検査の利用しやすさ、正確さ、手ごろさを高めることに注力することが、市場プレーヤーが既存の制約を克服しながらこのニッチを開拓する上で極めて重要であろう。市場が発展するにつれて、特に個別化医療とモバイルヘルス技術において、イノベーションのための肥沃な土壌が形成されることになります。

市場力学：急速に進化するビリルビン血液検査市場の主要市場インサイトを公開

ビリルビン血液検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 新生児ヘルスケアサービスの拡大による新生児のビリルビン検査需要の増加
  • ポイントオブケア検査の急増による利便性とビリルビン値の迅速な結果の促進
  • 頻繁なビリルビンモニタリングを必要とする溶血性疾患の発生率の増加が市場成長に寄与
  • 政府の医療政策と資金援助がビリルビン検査の進歩と利用しやすさを促進
• 市場抑制要因
  • 特に地方における、ビリルビン検査技術の訓練を受けた熟練ヘルスケア専門家の不足
  • 規制機関による新しいビリルビン検査法や技術の承認プロセスに時間がかかること
• 市場機会
  • 地方におけるビリルビン血液検査の普及を支えるヘルスケア政策
  • 新生児黄疸に対する意識の高まりによるビリルビン検査需要の増加
  • 革新的なビリルビン検査ソリューションのための病院と研究機関のパートナーシップ
• 市場の課題
  • ビリルビン血液検査キットのタイムリーでコスト効率の高い流通に影響するサプライチェーンの混乱
  • 革新的なビリルビン検査技術のイントロダクションの遅れにつながる承認プロセスにおける規制上の課題

ポーターの5つの力：ビリルビン血液検査市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ビリルビン血液検査市場における外部からの影響の把握

外部マクロ環境要因は、ビリルビン血液検査市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ビリルビン血液検査市場における競合情勢の把握

ビリルビン血液検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスビリルビン血液検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ビリルビン血液検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ビリルビン血液検査市場における成功への道筋を描く

ビリルビン血液検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報に基づいた意思決定を行う上で役立つ重要な質問にも回答しています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 新生児ヘルスケアサービスの拡大により新生児のビリルビン検査の需要が増加
    • 医療現場での検査の急増により、ビリルビン値の検査結果が便利かつ迅速に得られるようになりました。
    • 頻繁なビリルビンモニタリングを必要とする溶血性疾患の発生率の上昇が市場の成長に貢献
    • ビリルビン検査の進歩とアクセス性を促進する政府の健康政策と資金
  • 抑制要因
    • 特に地方では、ビリルビン検査技術の訓練を受けた熟練したヘルスケア従事者が不足しています。
    • 規制当局による新しいビリルビン検査方法と技術の承認プロセスは長い
  • 機会
    • 農村地域でのビリルビン血液検査の普及を支援するヘルスケア政策
    • 新生児黄疸に関する意識の高まりにより、ビリルビン検査の需要が増加
    • 革新的なビリルビン検査ソリューションのための病院と調査機関の提携
  • 課題
    • サプライチェーンの混乱により、ビリルビン血液検査キットのタイムリーかつコスト効率の良い配布が妨げられている
    • 承認プロセスにおける規制上の課題により、革新的なビリルビン検査技術のイントロダクションが遅れている
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTLE分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ビリルビン血液検査市場：検査タイプ別

• デルタビリルビン検査
• 直接ビリルビン（DBIL）検査
• 間接ビリルビン（IBIL）検査
• 総血清ビリルビン（TSB）検査
  • 直接（抱合型）ビリルビン検査
  • 間接（非抱合型）ビリルビン検査

第7章 ビリルビン血液検査市場：エンドユーザー別

• 外来手術センター（ASC）
• 診断検査室
• ホームケア設定
• 病院
• 研究機関

第8章 ビリルビン血液検査市場：用途別

• 胆管閉塞
• 薬物関連の毒性
• 溶血性貧血
• 肝臓疾患
• 新生児黄疸

第9章 ビリルビン血液検査市場：製品別

• 機器
• 試薬とキット

第10章 南北アメリカのビリルビン血液検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋のビリルビン血液検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのビリルビン血液検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 1. Abbott Laboratories
• 2. Agilent Technologies
• 3. Beckman Coulter
• 4. Bio-Rad Laboratories
• 5. DiaSorin
• 6. Fujifilm Holdings Corporation
• 7. GE Healthcare
• 8. Horiba Medical
• 9. Mindray
• 10. PerkinElmer
• 11. Philips Healthcare
• 12. Quidel Corporation
• 13. Randox Laboratories
• 14. Roche Diagnostics
• 15. Siemens Healthineers
• 16. Sysmex Corporation
• 17. Thermo Fisher Scientific
• 18. Tosoh Bioscience
• 19. Trinity Biotech

LIST OF FIGURES

• FIGURE 1. BILIRUBIN BLOOD TEST MARKET RESEARCH PROCESS
• FIGURE 2. BILIRUBIN BLOOD TEST MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. BILIRUBIN BLOOD TEST MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. BILIRUBIN BLOOD TEST MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BILIRUBIN BLOOD TEST MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BILIRUBIN BLOOD TEST MARKET DYNAMICS
• TABLE 7. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY DELTA BILIRUBIN TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY DIRECT BILIRUBIN (DBIL) TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY INDIRECT BILIRUBIN (IBIL) TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY DIRECT (CONJUGATED) BILIRUBIN TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY INDIRECT (UNCONJUGATED) BILIRUBIN TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY BILE DUCT OBSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY DRUG-RELATED TOXICITY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY HEMOLYTIC ANEMIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY LIVER DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY NEWBORN JAUNDICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. CANADA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 47. CANADA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 48. CANADA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. CANADA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. CANADA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. CHINA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 74. CHINA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 75. CHINA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. CHINA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. CHINA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. INDIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 79. INDIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 80. INDIA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. INDIA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. INDIA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. INDONESIA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. JAPAN BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. MALAYSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. PHILIPPINES BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. SINGAPORE BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. SOUTH KOREA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. TAIWAN BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. THAILAND BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. VIETNAM BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. DENMARK BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. EGYPT BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. FINLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. FRANCE BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 158. GERMANY BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. ISRAEL BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 164. ITALY BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 165. ITALY BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 166. ITALY BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 167. ITALY BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. ITALY BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. NETHERLANDS BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 178. NIGERIA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. NORWAY BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 184. POLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 185. POLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 186. POLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 187. POLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. POLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 189. QATAR BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 190. QATAR BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 191. QATAR BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 192. QATAR BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 193. QATAR BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 198. RUSSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 203. SAUDI ARABIA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 208. SOUTH AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 213. SPAIN BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 218. SWEDEN BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 223. SWITZERLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 228. TURKEY BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 233. UNITED ARAB EMIRATES BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 238. UNITED KINGDOM BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 239. BILIRUBIN BLOOD TEST MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 240. BILIRUBIN BLOOD TEST MARKET, FPNV POSITIONING MATRIX, 2023

The Bilirubin Blood Test Market was valued at USD 1.09 billion in 2023, expected to reach USD 1.20 billion in 2024, and is projected to grow at a CAGR of 10.73%, to USD 2.23 billion by 2030.

The bilirubin blood test market, encompassing diagnostic procedures to measure bilirubin levels in the blood, is pivotal in diagnosing and monitoring liver diseases, hemolytic anemia, and neonatal jaundice. The necessity of these tests is underscored by the increasing prevalence of liver disorders, driven by lifestyle changes, alcohol consumption, and viral infections like hepatitis. End-use applications predominantly include hospitals, diagnostic laboratories, and outpatient care centers, each requiring precise and timely diagnostic services to aid in patient management. Market growth is influenced by the rising demand for advanced diagnostic techniques, heightened awareness about liver health, and the increasing geriatric population, prone to liver diseases. Additionally, technological innovations such as point-of-care testing and the development of non-invasive diagnostic tools present substantial growth opportunities. Companies investing in R&D for more accurate and accessible testing methods stand to capitalize on the burgeoning demand. However, the market faces challenges like stringent regulatory requirements and the high costs associated with advanced testing technologies, which may constrain smaller laboratories and emerging economies. In terms of innovation, there is promising potential in exploring artificial intelligence-driven diagnostic tools to enhance test accuracy and patient outcomes. Additionally, research into more seamless integration of bilirubin testing in home-based settings could open new market segments. Despite these opportunities, the market is somewhat constrained by the lack of awareness and inadequate healthcare infrastructure in developing regions, highlighting a need for educational campaigns and infrastructure investments. Overall, focusing on enhancing test accessibility, accuracy, and affordability through technological advancements and strategic partnerships would be pivotal for market players to exploit this niche while overcoming existing limitations. As the market evolves, it presents a fertile ground for innovation, particularly in personalized medicine and mobile health technologies.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bilirubin Blood Test Market

The Bilirubin Blood Test Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Expansion of neonatal healthcare services increasing demand for bilirubin testing in newborns
  • Surge in point-of-care testing driving convenience and faster results for bilirubin levels
  • Higher incidence of hemolytic diseases requiring frequent bilirubin monitoring contributing to market growth
  • Government health policies and funding favoring advancements and accessibility of bilirubin testing
• Market Restraints
  • Shortage of skilled healthcare professionals trained in bilirubin testing techniques, especially in rural areas
  • Long approval process for new bilirubin test methods and technologies by regulatory bodies
• Market Opportunities
  • Healthcare policies supporting widespread adoption of bilirubin blood tests in rural areas
  • Rising awareness about neonatal jaundice leading to increased bilirubin testing demand
  • Partnerships between hospitals and research institutions for innovative bilirubin test solutions
• Market Challenges
  • Supply chain disruptions affecting timely and cost-efficient distribution of bilirubin blood test kits
  • Regulatory challenges in approval processes leading to delayed introduction of innovative bilirubin testing technologies

Porter's Five Forces: A Strategic Tool for Navigating the Bilirubin Blood Test Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bilirubin Blood Test Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bilirubin Blood Test Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bilirubin Blood Test Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bilirubin Blood Test Market

A detailed market share analysis in the Bilirubin Blood Test Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bilirubin Blood Test Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bilirubin Blood Test Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bilirubin Blood Test Market

A strategic analysis of the Bilirubin Blood Test Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bilirubin Blood Test Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Beckman Coulter, Bio-Rad Laboratories, DiaSorin, Fujifilm Holdings Corporation, GE Healthcare, Horiba Medical, Mindray, PerkinElmer, Philips Healthcare, Quidel Corporation, Randox Laboratories, Roche Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific, Tosoh Bioscience, and Trinity Biotech.

Market Segmentation & Coverage

This research report categorizes the Bilirubin Blood Test Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Test Type, market is studied across Delta Bilirubin Test, Direct Bilirubin (DBIL) Test, Indirect Bilirubin (IBIL) Test, and Total Serum Bilirubin (TSB) Test. The Total Serum Bilirubin (TSB) Test is further studied across Direct (Conjugated) Bilirubin Test and Indirect (Unconjugated) Bilirubin Test.
• Based on End User, market is studied across Ambulatory Surgical Centers (ASCs), Diagnostic Laboratories, Home Care Settings, Hospitals, and Research Institutes.
• Based on Application, market is studied across Bile Duct Obstruction, Drug-Related Toxicity, Hemolytic Anemia, Liver Diseases, and Newborn Jaundice.
• Based on Product, market is studied across Instruments and Reagents & Kits.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Expansion of neonatal healthcare services increasing demand for bilirubin testing in newborns
    • 5.1.1.2. Surge in point-of-care testing driving convenience and faster results for bilirubin levels
    • 5.1.1.3. Higher incidence of hemolytic diseases requiring frequent bilirubin monitoring contributing to market growth
    • 5.1.1.4. Government health policies and funding favoring advancements and accessibility of bilirubin testing
  • 5.1.2. Restraints
    • 5.1.2.1. Shortage of skilled healthcare professionals trained in bilirubin testing techniques, especially in rural areas
    • 5.1.2.2. Long approval process for new bilirubin test methods and technologies by regulatory bodies
  • 5.1.3. Opportunities
    • 5.1.3.1. Healthcare policies supporting widespread adoption of bilirubin blood tests in rural areas
    • 5.1.3.2. Rising awareness about neonatal jaundice leading to increased bilirubin testing demand
    • 5.1.3.3. Partnerships between hospitals and research institutions for innovative bilirubin test solutions
  • 5.1.4. Challenges
    • 5.1.4.1. Supply chain disruptions affecting timely and cost-efficient distribution of bilirubin blood test kits
    • 5.1.4.2. Regulatory challenges in approval processes leading to delayed introduction of innovative bilirubin testing technologies
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Bilirubin Blood Test Market, by Test Type

• 6.1. Introduction
• 6.2. Delta Bilirubin Test
• 6.3. Direct Bilirubin (DBIL) Test
• 6.4. Indirect Bilirubin (IBIL) Test
• 6.5. Total Serum Bilirubin (TSB) Test
  • 6.5.1. Direct (Conjugated) Bilirubin Test
  • 6.5.2. Indirect (Unconjugated) Bilirubin Test

7. Bilirubin Blood Test Market, by End User

• 7.1. Introduction
• 7.2. Ambulatory Surgical Centers (ASCs)
• 7.3. Diagnostic Laboratories
• 7.4. Home Care Settings
• 7.5. Hospitals
• 7.6. Research Institutes

8. Bilirubin Blood Test Market, by Application

• 8.1. Introduction
• 8.2. Bile Duct Obstruction
• 8.3. Drug-Related Toxicity
• 8.4. Hemolytic Anemia
• 8.5. Liver Diseases
• 8.6. Newborn Jaundice

9. Bilirubin Blood Test Market, by Product

• 9.1. Introduction
• 9.2. Instruments
• 9.3. Reagents & Kits

10. Americas Bilirubin Blood Test Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Bilirubin Blood Test Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Bilirubin Blood Test Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Agilent Technologies
• 3. Beckman Coulter
• 4. Bio-Rad Laboratories
• 5. DiaSorin
• 6. Fujifilm Holdings Corporation
• 7. GE Healthcare
• 8. Horiba Medical
• 9. Mindray
• 10. PerkinElmer
• 11. Philips Healthcare
• 12. Quidel Corporation
• 13. Randox Laboratories
• 14. Roche Diagnostics
• 15. Siemens Healthineers
• 16. Sysmex Corporation
• 17. Thermo Fisher Scientific
• 18. Tosoh Bioscience
• 19. Trinity Biotech